IDWeek Video Pearls
<ѻý class="page-description">Video Pearls from the Joint Meeting of IDSA, SHEA, HIVMA, and PIDSѻý>In a phase Ia trial, long-acting integrase inhibitor was associated with very few adverse events
High adherence, persistence, and safety shown in diverse populations over first 2 years
Vaccination tied to fewer hospitalizations and emergency department visits
AHRQ was designed to build antibiotic stewardship as an important approach to patient safety
Joshua Hill, MD, says the antiviral treatment "provides another tool in our tool belt"
Jessica Castilho, MD, MPH, hopes we can work toward figuring out why
Matthew Spinelli, MD, says patients with lower CD4 counts should be prioritized for boosters
Research suggests that TDF actually suppresses body weight
Routine tests for HIV went down during the pandemic
Matthew Spinelli, MD, is worried "this could be an omen of what we could see in the next year"
Doug Krakower debates with Annie Luetkemeyer at IDWeek 2020
-
IDWeek: A Joint Meeting of IDSA, SHEA, HIVMA, PIDS, and SIDP
October 2024
-
CROI: Conference on Retroviruses and Opportunistic Infections
March 2024
-
ASTMH: American Society of Tropical Medicine & Hygiene
October 2022
-
IDWeek Podcast: Podcast from the Joint Meeting of IDSA, SHEA, HIVMA, and PIDS
October 2020